Nonprofit · EIN 75-1921898
BAYLOR RESEARCH INSTITUTE
Tax-exempt · DALLAS, TX 75246
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $89,491,341 | $85,910,172 | $3,581,169 | $191,870,643 | $18,971,610 | $172,899,033 |
| June 30, 2024 | 990 | $84,907,337 | $78,415,673 | $6,491,664 | $171,591,125 | $13,744,609 | $157,846,516 |
| June 30, 2023 | 990 | $73,307,762 | $76,665,102 | -$3,357,340 | $157,601,006 | $11,604,695 | $145,996,311 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $42,035,733
- of which government grants
- $16,000,056
- Program service revenue
- $33,238,900
- Investment income
- $1,542,656
- Royalties
- $11,610,582
- Other revenue
- $12,674,052
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $1,674,482
- Other salaries and wages
- $45,208,816
- Salaries, compensation and benefits (total)
- $55,678,294
- Professional fundraising fees
- $0
- Legal fees
- $108,119
- Occupancy
- $3,324,866
- Travel
- $512,441
- Depreciation
- $1,761,714
- Program services (functional)
- $75,562,410
- Management and general (functional)
- $10,347,762
Balance sheet and other
- Total assets, start of year
- $171,591,125
- Total assets, end of year
- $191,870,643
- Total liabilities, end of year
- $18,971,610
- Net assets, end of year
- $172,899,033
- Land, buildings and equipment
- $6,485,228
- Publicly traded securities
- $7,753,153
- Net assets without donor restrictions
- $46,658,625
- Net assets with donor restrictions
- $126,240,408
- Gross receipts
- $89,491,341
- Employees
- 594
- Volunteers
- 0
- Year formed
- 1982
- State of legal domicile
- TX
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Steven Newton | Trustee Trustee or director | 1 | $0 | $2,931,092 | $46,363 |
| Alejandro Arroliga MD | Trustee Trustee or director | 1 | $0 | $2,620,998 | $48,385 |
| Javed Butler MD | Trustee/President/CEO Trustee or director, Officer | 40 | $806,185 | $0 | $109,507 |
| Michael J Mack MD | Trustee/Chair Trustee or director, Officer | 1 | $0 | $605,049 | $21,529 |
| Mitch Dean | Secretary Officer | 1 | $0 | $444,345 | $61,698 |
| Amy Martin | VP CFO Officer | 1 | $0 | $423,050 | $77,661 |
| Elisa Priest | Director Clinical Informatics Highest-paid employee | 40 | $327,925 | $0 | $67,962 |
| Jennifer Thomas | VP Research Operations Key employee | 40 | $330,334 | $0 | $39,886 |
| Elizabeth Cothran | VP Chief Regulatory Officer Key employee | 40 | $309,167 | $0 | $48,847 |
| Gerard Zurawski | Dir Institute Immun Rsrch Highest-paid employee | 40 | $315,598 | $0 | $25,054 |
| Alan Stevens | Research Center Dir Highest-paid employee | 40 | $295,784 | $0 | $36,711 |
| Suzy Gulliver | Research Center Dir Highest-paid employee | 40 | $284,849 | $0 | $36,656 |
| Simon Driver | Research Center Dir Highest-paid employee | 40 | $277,664 | $0 | $38,264 |
990 for the year ended June 30, 2024: 13 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Steven Newton | Trustee Trustee or director | 1 | $0 | $3,595,037 | $631,482 |
| Alejandro Arroliga MD | Trustee Trustee or director | 1 | $0 | $3,306,664 | $638,925 |
| Javed Butler MD | Trustee/President/CEO Trustee or director, Officer | 40 | $753,435 | $0 | $90,922 |
| Michael J Mack MD | Trustee/Chair Trustee or director, Officer | 1 | $0 | $605,049 | $20,779 |
| Mitch Dean | Secretary Officer | 1 | $0 | $406,852 | $57,645 |
| Amy Martin | VP CFO Officer | 1 | $0 | $389,259 | $75,161 |
| Jennifer Thomas | VP Research Operations Key employee | 40 | $312,494 | $0 | $42,848 |
| Elizabeth Cothran | VP Chief Regulatory Officer Key employee | 40 | $299,147 | $0 | $45,848 |
| Gerard Zurawski | Dir Institute Immun Rsrch Highest-paid employee | 40 | $315,436 | $0 | $24,904 |
| Alan Stevens | Research Center Dir Highest-paid employee | 40 | $297,403 | $0 | $32,849 |
| Elisa Priest | Director Clinical Informatics Highest-paid employee | 40 | $277,993 | $0 | $50,898 |
| Simon Driver | Research Center Dir Highest-paid employee | 40 | $289,292 | $0 | $36,234 |
| Suzy Gulliver | Research Center Dir Highest-paid employee | 40 | $268,706 | $0 | $35,432 |
990 for the year ended June 30, 2023: 13 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Alejandro Arroliga MD | Trustee Trustee or director | 1 | $0 | $1,677,582 | $438,520 |
| Steven Newton | Trustee Trustee or director | 1 | $0 | $1,595,379 | $401,848 |
| Michael J Mack MD | Trustee/Chair Trustee or director, Officer | 1 | $0 | $705,092 | $19,486 |
| Javed Butler MD | Trustee/President/CEO Trustee or director, Officer | 40 | $631,586 | $0 | $64,063 |
| Amy Martin | VP CFO Officer | 1 | $0 | $373,384 | $72,515 |
| Mitch Dean | Secretary Officer | 1 | $0 | $371,817 | $53,564 |
| Gerard Zurawski | Dir Institute Immun Rsrch Highest-paid employee | 40 | $319,620 | $0 | $15,779 |
| Jennifer Thomas | VP Research Operations Key employee | 40 | $289,273 | $0 | $41,468 |
| Elizabeth Cothran | VP Chief Regulatory Officer Key employee | 40 | $276,951 | $0 | $44,778 |
| Alan Stevens | Research Center Dir Highest-paid employee | 40 | $293,674 | $0 | $26,640 |
| Simon Driver | Research Center Dir Highest-paid employee | 40 | $275,746 | $0 | $34,435 |
| Suzy Gulliver | Research Center Dir Highest-paid employee | 40 | $253,128 | $0 | $33,479 |
| Teodoro Bottiglieri | Dir Institute Immun Rsrch Highest-paid employee | 40 | $255,349 | $0 | $21,688 |
Address and contacts
- Address (IRS master file)
- 301 N WASHINGTON AVE, DALLAS, TX 75246-1754
- In care of
- % BSWH TAX SERVICES
- Principal officer (990 for 2024)
- Javed Butler, 3434 Live Oak, Dallas, TX 75204
- Signed the 990
- Amy Martin, VP CFO
- Phone
- (214) 820-4135
- Website
- www.bswhealth.com
Mission
To improve the care and well being of our community, nationally and internationally, through innovative clinically relevant research that is consistent with the mission, vision and values of Baylor Scott & White Health (BSWH).
Program accomplishments
- See Schedule OEstablished in 1984, Baylor Scott & White Research Institute (BSWRI) is responsible for the oversight and management of all translational, observational, and clinical research conducted throughout the Baylor Scott & White Health (BSWH) system.BSWRI expanded its operations in 2013 as part of the merger between Dallas-based Baylor Health Care System and Temple-based Scott & White Healthcare, which created BSWH the largest nonprofit health system in Texas. Today, BSWH has over 1,300 patient access points including 53 hospitals, 600+ specialty care clinics, 250+ outpatient clinics, 150+ primary care clinics, 29 pharmacies, 30+ ambulatory surgery centers, 60+ urgent care clinics, and over 7,300 active physicians. The system also includes a state certified health maintenance organization, the Scott and White Health Plan and the Baylor Scott & White Quality Alliance accountable care organization both covering approximately 1,200,000 lives.BSWRI brings innovation to the forefront of medicine. From contributing to discoveries that help create new treatment options, to studying population health and other trends that improve quality of care, we pursue research focused on bringing patients greater value and addressing the health needs of the communities we serve. We are dedicated to advancing healthcare and ultimately, patient care, through the study and discovery of new preventive therapies and treatments for a broad spectrum of diseases and other chronic conditions. This means our efforts extend beyond microscopic studies; they bring innovation to the patient's bedside. We focus on understanding the base of a disease or condition, in order to then identify potential treatments or preventive therapies and enroll patients in research trials to further test and/or validate each theory. BSWRI is accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), which is a voluntary, peer-driven, and education-based model of accreditation.BSWRI is home to a rich network of over 600 team members operating within two administrative offices, four clinical trials offices, and directly within various BSWH centers, hospitals and clinics. Research staff include principal investigators, contracts and finance specialists, compliance and regulatory specialists, research coordinators, nurses, managers, data analysts and lab assistants, among others. The group oversees research activities supporting over 1,200studies in more than 50 specialty areas annually, including infectious disease, cardiology, gastroenterology, trauma, rehabilitation, neurology, oncology and radiation, orthopedics, pathology, radiology, transplant and surgery. Research conducted by and supported by our organization is regularly published in major scientific journals and reported at medical and scientific meetings. This work has also resulted in more than 1,600 issued and pending patents and trademark registrations spanning immunotherapy, genomics, biomarkers, metabolomics, metabolics, cardiovascular disease and medical devices. The following is a brief snapshot of activities led through BSWRI:Cardiovascular research: BSWRI holds a robust cardiovascular portfolio with study enrollment activities spanning multiple BSWH sites. Each year, we enroll and monitor hundreds of patients as part of major clinical trials examining therapeutic and surgical approaches and outcomes, new medications and new devices. Our cardiovascular research portfolio supports trials spanning: Atrial Fibrillation, Vascular/TAA conditions, Heart Failure Transplant, Heart Rhythm Disorders, Hypercholesterolemia, Aortic Valve Disorders, Cardiorenal Syndrome, Electrophysiology, Coronary Artery Disease, & Mitral Valve Disorders.Oncology research: The newest research hub within BSWRI is the Texas Cancer Interception Institute (TCII), created to attract and conduct innovative oncology clinical trials and research projects to help advance the science. Through advanced diagnostics, ground-breaking research, AI-enabled digital technology solutions, sophisticated meta-data analytics, and patient-centered support and command center, TCII is an innovation powerhouse transforming discoveries into life-changing treatments and leading early cancer detection efforts across Texas and beyond. TCII is uniquely empowered to lead 'implementation science' across BSWH via utilization of its state-of-the-science Oncology Command Center for development of various care coordination capabilities to offer novel early cancer detection pathways (such as blood-based Multi-Cancer Early Detection or MCED assays) and facilitate navigation of patients for timely, high-quality and reliable care across BSWH for cancer interception.The Center for Applied Health Research (CAHR) supports competitively funded investigator-initiated research to generate applied health knowledge across our health care system.It is a multidisciplinary, system-level research center within the Baylor Scott & White Research Institute (BSWRI) and serves as a collaborative for researchers, clinicians and community leaders who seek to improve health care delivery and health outcomes. The core value of CAHR is to support innovations that lead to improve outcomes and the value of care for our patients and community. We are located in Temple and Dallas, Texas.CAHR's research programs include: (1) Intervention development of community and family support programs for persons with dementia and their family caregivers (2) Implementation science of evidence-based programs leading to innovations in care delivery (3) Dissemination of evidence-based programs/practices for older adults from diverse settings (4) Healthcare delivery implementation programs to address critical illness outside of the ICU (5) Intervention development to support patients and families after critical illness and (6) Real-world clinical and economic evidence generation focused on drug therapy outcomes in ambulatory care.Trauma and behavioral health research: BSWRI supports trauma and behavioral health research across multiple sites and departments. Our research investigators take a collaborative and multidisciplinary approach to address physical, mental, and emotional trauma, which enhances ability to combine resources, inform best practices and further expand our ability to share our learnings out to others. One example of this work is found in the Warriors Research Institute (WRI). WRI's mission is to improve the quality of care available to military veterans and emergency responders via a program of scientific inquiry. Through BSWRI, WRI develops, evaluates, and disseminates information about treatment models for those suffering the sequelae of toxic or traumatic work events. In addition to providing and evaluating state-of-the-art experimental treatments, we train future generations of treatment providers in evolving evidence-based care. A second example is with the work done by the Trauma Research Center and Behavioral Health departments. These teams bring together the efforts of experienced researchers whose research focuses on trauma and related conditions resulting from a variety of etiologies including life events and the psychological conditions resulting from trauma. These researchers work closely with the trauma centers and rehabilitation teams at BSWH as well as external trauma centers across the country. They also study the psychological impacts of trauma-exposed occupational populations, such as healthcare personnel and active-duty service members.Transplant research: Our research efforts around transplantation take place at multiple sites including Baylor Scott & White All Saints Medical Center - Fort Worth, Baylor University Medical Center and Baylor Scott & White Medical Center - Temple. This research continues to hit major milestones and research firsts. BSWRI supports multiple trials examining transplant procedures and post-op care, as well as addressing transplant waitlists and organ shortages. Our efforts in the specialty of abdominal transplant, as well as heart and lung transplants, continue to support efforts to improve outcomes, inform access to organs, and educate medical staff on best practices. These include an investigator-initiated studies examining issues such as the global burden of alcohol-associated liver disease and the impact of new acuity circle policies for liver allocation. This work also extends to studies examining new artificial heart technologies for individuals needing a heart transplant.Expenses $75,562,410 · revenue $34,302,370
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 75-1921898
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Hospital or medical research organization
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1984
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H900)
- Assets (IRS master file)
- $191,870,643
- Income (IRS master file)
- $89,491,341
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $89,491,341 | $85,910,172 | $191,870,643 | IRS |
| 990 | June 2024 | $84,907,337 | $78,415,673 | $171,591,125 | IRS |
| 990 | June 2023 | $73,307,762 | $76,665,102 | $157,601,006 | XML |
| 990 | June 2022 | $70,312,625 | $68,170,124 | $163,970,510 | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990 | June 2020 | – | – | – | IRS |
| 990 | June 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 75-1921898).
Questions about BAYLOR RESEARCH INSTITUTE
- What is the EIN of BAYLOR RESEARCH INSTITUTE?
- The employer identification number (EIN) of BAYLOR RESEARCH INSTITUTE is 75-1921898.
- Is BAYLOR RESEARCH INSTITUTE tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1984.
- Are donations to BAYLOR RESEARCH INSTITUTE tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does BAYLOR RESEARCH INSTITUTE file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of BAYLOR RESEARCH INSTITUTE due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did BAYLOR RESEARCH INSTITUTE last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of BAYLOR RESEARCH INSTITUTE?
- The 990 for the year ended June 30, 2025 names Javed Butler.
- Who are the officers and directors of BAYLOR RESEARCH INSTITUTE?
- The 990 for the year ended June 30, 2025 lists 13 people; 8 received compensation from the organization.
- How much revenue does BAYLOR RESEARCH INSTITUTE have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $89,491,341, expenses of $85,910,172 and total assets of $191,870,643 at year end.
Other nonprofits in DALLAS
- RETINA FOUNDATION OF THE SOUTHWEST EIN 51-0151514 · last filed 990 for 2025
- CHILDRENS MEDICAL CENTER RESEARCH INSTITUTE AT THE UNIVERSITY OF TEX EIN 45-3462044 · last filed 990 for 2024
- NATIONAL OVARIAN CANCER COALITION INC EIN 65-0628064 · last filed 990 for 2024
- KIDNEY CANCER ASSOCIATION EIN 36-3719712 · last filed 990 for 2025
- OSTEOSARCOMA INSTITUTE EIN 82-2921815 · last filed 990 for 2024
- DALLAS VA RESEARCH CORPORATION EIN 75-2329831 · last filed 990 for 2025
- PEDIATRIC EPILEPSY RESEARCH FOUNDATION EIN 20-1779737 · last filed 990-PF for 2024
- CHILDRENS CANCER FUND OF DALLAS INC EIN 75-2113401 · last filed 990 for 2025